The Role of O-Antigen in LPS-Induced Activation of Human NK Cells

NK cells can be stimulated by bacterial lipopolysaccharides (LPS). Unlike macrophages, human NK cells do not express or express very low level of surface TLR4 receptor normally required for the LPS stimulation. This has led to the assumption that the mechanisms of stimulating action of LPS on macrophages and NK cells differs. In this work, we investigated the effects of different forms of E. coli LPS, including mutants lacking O-antigen structures, and deacylated LPS on IFNγ production by purified human NK cells. The main findings were the following: (1) NK cells were more sensitive to the S-forms of LPS than the R-forms (LPS lacking O-antigen); (2) LPS triggered a significant increase in IFNγ production by NK cells in concentrations about 1000 times higher than those that can induce cytokine production by macrophages; (3) the composition and structure of saccharide part of LPS have a strong influence on its observed effects on NK cells; and (4) LPS fully retained the ability to trigger cytokine production in NK cells in serum-free media. The acquired data demonstrated that the presence and structure of O-antigen affects the LPS-induced activation of human NK cells.

[1]  W. Telford,et al.  HLA‐DR+ NK cells are mostly characterized by less mature phenotype and high functional activity , 2018, Immunology and cell biology.

[2]  W. Telford,et al.  Bacterial lipopolysaccharide activates CD57-negative human NK cells , 2014, Biochemistry (Moscow).

[3]  J. Cavaillon,et al.  Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty? , 2013, Critical Care.

[4]  B. Lindner,et al.  Intact rough‐ and smooth‐form lipopolysaccharides from Escherichia coli separated by preparative gel electrophoresis exhibit differential biologic activity in human macrophages , 2013, The FEBS journal.

[5]  W. Telford,et al.  Lipopolysaccharide induces IFN-γ production in human NK cells , 2013, Front. Immun..

[6]  R. Fernandez,et al.  Recognition of lipid A variants by the TLR4-MD-2 receptor complex , 2012, Front. Cell. Inf. Microbio..

[7]  J. Cavaillon,et al.  Toll-like receptors expression and interferon-γ production by NK cells in human sepsis , 2012, Critical Care.

[8]  C. Kallenberg,et al.  Increased Expression of Toll-Like Receptors by Monocytes and Natural Killer Cells in ANCA-Associated Vasculitis , 2011, PloS one.

[9]  L. Chiche,et al.  The Role of Natural Killer Cells in Sepsis , 2011, Journal of biomedicine & biotechnology.

[10]  E. Riley,et al.  A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG , 2011, European journal of immunology.

[11]  M. Dathe,et al.  Interaction of W-Substituted Analogs of Cyclo-RRRWFW with Bacterial Lipopolysaccharides: the Role of the Aromatic Cluster in Antimicrobial Activity , 2010, Antimicrobial Agents and Chemotherapy.

[12]  F. Calzetti,et al.  On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. , 2009, Immunobiology.

[13]  G. Plitas,et al.  Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function. , 2008, Human immunology.

[14]  Göran Widmalm,et al.  The structures of Escherichia coli O-polysaccharide antigens. , 2006, FEMS microbiology reviews.

[15]  Zhengfan Jiang,et al.  R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells , 2006, European journal of immunology.

[16]  H. Heine,et al.  The biology of endotoxin. , 2001, Molecular biotechnology.

[17]  C. Whitfield,et al.  Distribution of Core Oligosaccharide Types in Lipopolysaccharides from Escherichia coli , 2000, Infection and Immunity.

[18]  E. Greenberg,et al.  The basis of silver staining of bacterial lipopolysaccharides in polyacrylamide gels , 2005, Current Microbiology.

[19]  C. Frasch,et al.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. , 1982, Analytical biochemistry.

[20]  R. Elin,et al.  Biology of endotoxin. , 1976, Annual review of medicine.